Skip to content

Strybol Wout Pharma

Active
Private limited companyfounded 2018active for 8 yearsZilversparrenstraat 29, 8310 Brugge, BelgiumKBO/BCE: BE 0712.514.587

From the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Strybol Wout Pharma has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €56,774 and a net result of €155,593. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 15% of 2,812 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
Strybol Wout PharmaActiveChecked score 90/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 24-10-2018 Normal situation
Legal form
Private limited company
Registered office
Zilversparrenstraat 29, 8310 Brugge
Activity
Other business support services NACE 82990
Establishment unit
2.281.832.354 9990 Maldegem, since 24-10-2018
Financial year end
31 December
Peppol
Reachable since 30-01-2025
Company details

Who decides

Board
Holdings
Shares in 7 companies including STRYBOL DE ZEVEN TORENTJES and STRYBOL SINT-TRUDO
Board & ownership

How it is doing

90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€232,433
▲ 413%
Turnover
≈ €350,000
estimated
Profit
€155,593
▲ 374%
Equity
€56,774
▲ 10.4%
Total assets
€2.2m
▲ 14×
2025 accounts 29 days early
Filed on 02-07-2026at the National Bank
Financials
Why 90raises riskLiquidity: current ratio 0.26, cash €12,243, halvedEquity €56,774 (2.6% of total assets)lowers riskSize: total assets €2.2mSector: Office administrative, office support and other business support activities (NACE 82)Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 46% of its sector peers (NACE 82, small)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 28-29
equity 2.6% of total assets
Liquidity 45-16
short-term debt 19.6% · cash 0.6%
Profitability 78-17
return on assets 7.2%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (1,120 companies, NACE 82, small)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: < 0.1%▼ -0.1 percentage points vs 05-2025lowest value 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026highest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.26, compared with 0.64 in 2024, below 1; short-term debt: 19.6% and cash: 0.6% of total assets), and 97.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 82, small): better than 10% on solvency, 35% on liquidity, 75% on profitability and 64% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €2.2m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Sector: Office administrative, office support and other business support activities (NACE 82)
KBO
raises risk · Liquidity: current ratio 0.26, cash €12,243, halved
NBB · annual accounts
raises risk · Equity €56,774 (2.6% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 2812 sector peers (2025).
NBB · sector comparison
Position among 2812 sector peers
Solvency
better than 15%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
29 days early
2024
9 days early
2023
1 day early
2022
24 days early
2021
24 days early
2020
29 days early
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 17 days before the deadline; the sector median (NACE 82) for financial year 2024 is 7 days before the deadline, and 35% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: Result rose in 2025from €32,804 to €155,593 ▲ 374% View
  • Caution: Among the weakest 15% on solvencysector median 41.4% · 2,812 companies 2.6% View
  • Positive: Always filed on timeaccounts within the deadline every year 7 years View
  • Positive: 7 profitable years in a rowprofit 2025: €155,593 7 years View

Documents

Annual accounts at the NBB

All 7 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Strybol Wout Pharma

What is the company number of Strybol Wout Pharma?
0712.514.587. In Belgium the VAT number is the company number with BE in front: BE 0712.514.587.
Where is Strybol Wout Pharma based?
The registered office is at Zilversparrenstraat 29, 8310 Brugge.Company details
What does Strybol Wout Pharma do?
According to the KBO register, the main activity is other business support services (NACE 82990).
What is the legal form of Strybol Wout Pharma?
Private limited company (BV).
When was Strybol Wout Pharma founded?
On 24-10-2018.
Is Strybol Wout Pharma still active?
Yes, Strybol Wout Pharma is an active enterprise in the KBO register.
What is the turnover of Strybol Wout Pharma?
≈ €350,000 in financial year 2025. Estimated from the gross margin of €232,433: probably between €280,000 and €480,000, based on 31 comparable companies, NACE 82990.Financials
Is Strybol Wout Pharma profitable?
In financial year 2025, Strybol Wout Pharma made a profit of €155,593.
Where can I find the annual accounts of Strybol Wout Pharma?
Strybol Wout Pharma filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Strybol Wout Pharma due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Strybol Wout Pharma

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure